Will Benchmark New Ratings Coverage and $2.5 Target Help Nobilis Health (US:HLTH) Stock Today?

Share with your friends










Submit

NewYork Nobilis Health US:HLTH

Nobilis Health (US:HLTH) Price Target & New Coverage by Benchmark

Benchmark issued “Buy” rating on Nobilis Health (US:HLTH). The firm has initiated coverage on shares of HLTH in analysts note revealed on 19 May. Benchmark’s TP gives upside of 85.19 % from the company’s previous stock close.

Despite the new coverage US:HLTH is right now trading 0.00% lower at $1.35 as of 4:03 AM New York time. Nobilis Health shares have [From2] 0% over the past 200 days, while the S&P500 Index has gained 6.00% for the same time.

HLTH Stock Chart

Nobilis Health (US:HLTH) Profile

Nobilis Health Corp. (Nobilis) owns and manages healthcare facilities in the States of Texas and Arizona, consisting primarily of ambulatory surgery centers (ASCs) and acute-care and surgical hospitals. The Company’s segments include Medical Services, Marketing Services and Corporate. The Medical Services segment owns and manages approximately nine healthcare facilities in Texas and Arizona; over four hospitals, and approximately five ambulatory surgery centers.

Nobilis Health (US:HLTH) closed at $1.35 yesterday. A total of 246,510 shares of the company’s stock traded hands. This is down from average of 790,836 shares. Nobilis Health has a 52 week low of $1.10 and a 52 week high of $3.86. The company has a market cap of $105.04M and a P/E ratio of 11.25.

Get the latest Nobilis Health (US:HLTH) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.